Area of research
Cancer Research · Oncology
Research interest
Research focused on Cancer research and Clear cell renal cell carcinoma, with related work in Wnt signaling pathway, Renal cell carcinoma, Epigenetics. Notable publications include 'Nek2B activates the wnt pathway and promotes triple-negative breast cancer chemothezrapy-resistance by stabilizing β-catenin', 'Down-regulation of human leukocyte antigen class I (HLA-I) is associated with poor prognosis in patients with clear cell renal cell carcinoma', and 'Epigenetic silencing of ASPP1 confers 5‐FU resistance in clear cell renal cell carcinoma by preventing p53 activation'.
Nek2B activates the wnt pathway and promotes triple-negative breast cancer chemothezrapy-resistance by stabilizing β-catenin
Epigenetic silencing of ASPP1 confers 5‐FU resistance in clear cell renal cell carcinoma by preventing p53 activation
Lin28A and androgen receptor expression in ER−/Her2+ breast cancer
Survivin and HLA-I expression predicts survival of patients with clear cell renal cell carcinoma
Down-regulation of human leukocyte antigen class I (HLA-I) is associated with poor prognosis in patients with clear cell renal cell carcinoma
Utility of fluorescence in situ hybridization for the diagnosis of bladder urothelial carcinoma